Invitae Corporation
Index- P/E- EPS (ttm)-13.48 Insider Own1.30% Shs Outstand232.12M Perf Week-50.75%
Market Cap839.80M Forward P/E- EPS next Y-1.79 Insider Trans-5.88% Shs Float231.96M Perf Month92.31%
Income-3108.60M PEG- EPS next Q-0.62 Inst Own80.80% Short Float22.32% Perf Quarter11.84%
Sales500.80M P/S1.68 EPS this Y59.80% Inst Trans2.04% Short Ratio2.78 Perf Half Y-61.78%
Book/sh1.66 P/B2.56 EPS next Y30.50% ROA-72.90% Target Price4.00 Perf Year-83.53%
Cash/sh3.68 P/C1.16 EPS next 5Y8.00% ROE-133.50% 52W Range1.83 - 32.93 Perf YTD-72.17%
Dividend- P/FCF- EPS past 5Y9.90% ROI-7.70% 52W High-88.45% Beta1.89
Dividend %- Quick Ratio6.10 Sales past 5Y79.00% Gross Margin21.90% 52W Low107.92% ATR1.03
Employees2300 Current Ratio6.40 Sales Q/Q17.50% Oper. Margin- RSI (14)51.92 Volatility32.19% 28.45%
OptionableYes Debt/Eq4.14 EPS Q/Q- Profit Margin- Rel Volume1.21 Prev Close4.25
ShortableYes LT Debt/Eq4.12 EarningsAug 09 AMC Payout- Avg Volume18.66M Price3.81
Recom3.10 SMA2022.80% SMA5034.67% SMA200-57.89% Volume9,467,990 Change-10.47%
Aug-10-22Downgrade JP Morgan Neutral → Underweight
Jul-26-22Downgrade Cowen Outperform → Market Perform $8 → $2.50
Jul-21-22Downgrade Raymond James Outperform → Mkt Perform
Jul-20-22Downgrade Ladenburg Thalmann Buy → Neutral
Jul-19-22Downgrade The Benchmark Company Buy → Hold
Jul-19-22Downgrade SVB Leerink Outperform → Mkt Perform
Jun-03-22Initiated Piper Sandler Underweight $2.50
Aug-04-21Upgrade The Benchmark Company Hold → Buy $35
Jun-15-21Initiated Raymond James Outperform $37
Jun-03-21Initiated Goldman Neutral $33
May-25-21Initiated Wells Fargo Equal Weight $30
Apr-05-21Upgrade Oppenheimer Perform → Outperform $48
Feb-18-21Upgrade Ladenburg Thalmann Neutral → Buy $46.50 → $58
Feb-01-21Downgrade Oppenheimer Outperform → Perform
Oct-14-20Downgrade JP Morgan Overweight → Neutral
Sep-09-20Initiated Morgan Stanley Equal-Weight $38
Jul-01-20Downgrade The Benchmark Company Buy → Hold
Aug-07-19Reiterated The Benchmark Company Buy $26 → $28
Mar-04-19Initiated Chardan Capital Markets Buy $29
Dec-19-18Initiated Oppenheimer Outperform
Aug-18-22 09:15AM  
Aug-15-22 08:27AM  
Aug-14-22 10:23AM  
Aug-13-22 05:31AM  
Aug-12-22 10:02PM  
Aug-11-22 02:43PM  
Aug-10-22 03:54PM  
Aug-09-22 05:25PM  
Aug-08-22 06:25PM  
Aug-04-22 07:15PM  
Aug-02-22 09:11AM  
Jul-29-22 06:20PM  
Jul-27-22 10:02AM  
Jul-26-22 10:01AM  
Jul-21-22 06:45PM  
Jul-19-22 03:42PM  
Jul-18-22 04:13PM  
Jul-08-22 07:29AM  
Jul-02-22 07:15AM  
Jun-20-22 05:15AM  
Jun-03-22 04:45PM  
Jun-01-22 04:42PM  
May-31-22 05:31AM  
May-27-22 07:00AM  
May-26-22 05:05PM  
May-21-22 08:00AM  
May-19-22 06:30AM  
May-16-22 09:00AM  
May-13-22 04:17PM  
May-06-22 05:11AM  
May-05-22 03:33PM  
May-04-22 11:12AM  
May-03-22 10:00PM  
Apr-28-22 11:07AM  
Apr-26-22 06:00PM  
Apr-20-22 06:59AM  
Apr-11-22 11:28AM  
Apr-04-22 06:30AM  
Mar-30-22 08:05AM  
Mar-29-22 06:30AM  
Mar-22-22 03:50PM  
Mar-21-22 02:25PM  
Mar-17-22 06:30AM  
Mar-16-22 02:35PM  
Mar-15-22 04:30PM  
Mar-09-22 11:23AM  
Feb-24-22 06:10PM  
Feb-23-22 10:59AM  
Feb-16-22 03:00AM  
Feb-10-22 06:59AM  
Feb-09-22 03:01PM  
Feb-08-22 09:38AM  
Feb-04-22 03:08PM  
Feb-03-22 11:28PM  
Feb-02-22 05:38PM  
Jan-27-22 01:38PM  
Jan-26-22 05:38PM  
Jan-21-22 01:38PM  
Jan-20-22 10:01AM  
Jan-11-22 01:13PM  
Jan-10-22 12:03PM  
Jan-05-22 07:30AM  
Dec-25-21 11:00AM  
Dec-22-21 03:03PM  
Dec-12-21 10:43AM  
Dec-10-21 12:38PM  
Dec-08-21 09:23AM  
Nov-30-21 05:24AM  
Nov-25-21 11:54AM  
Nov-19-21 12:03PM  
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WERNER ROBERT F.Chief Accounting OfficerMay 19Sale3.402,7469,336201,909May 19 07:06 PM
WERNER ROBERT F.Chief Accounting OfficerMay 17Sale3.817,35628,027204,655May 19 07:06 PM
Knight Kenneth D.Chief Operating OfficerMay 17Sale3.8128,295107,807518,895May 19 05:45 PM
Brida ThomasSee RemarksMay 17Sale3.816,09823,234393,315May 19 05:30 PM
George Sean EPresident & CEOMay 17Sale3.8118,29669,710794,691May 19 05:28 PM
Wen YafeiChief Financial OfficerMay 17Sale3.8117,04264,932344,374May 19 05:27 PM
Nussbaum Robert LChief Medical OfficerMay 17Sale3.816,09823,234403,580May 19 05:26 PM
George Sean EPresident & CEOMar 14Sale6.6931,389209,886812,987Mar 16 08:56 PM
Wen YafeiChief Financial OfficerMar 14Sale6.693,28921,992136,416Mar 16 08:54 PM
Brida ThomasGeneral CounselMar 14Sale6.6917,987120,286229,739Mar 16 08:55 PM
Nussbaum Robert LChief Medical OfficerMar 14Sale6.6919,588130,993241,167Mar 16 08:52 PM
Knight Kenneth D.Chief Operating OfficerMar 14Sale6.692,35815,767322,190Mar 21 04:31 PM
Nussbaum Robert LChief Medical OfficerNov 11Option Exercise10.0829,675299,196275,725Nov 15 05:07 PM
Nussbaum Robert LChief Medical OfficerNov 11Sale21.8929,675649,568246,050Nov 15 05:07 PM
George Sean EPresident & CEOOct 22Sale28.063,675103,120800,259Oct 26 05:49 PM
George Sean EPresident & CEOSep 27Option Exercise3.9055,000214,500803,934Sep 28 04:05 PM
George Sean EPresident & CEOSep 22Sale31.887,350234,306748,934Sep 24 04:05 PM
WERNER ROBERT F.Chief Accounting OfficerAug 19Sale24.8615,337381,31873,980Aug 20 06:15 PM